T. Rowe Price Associates’s Assembly Biosciences ASMB Stock Holding History
Bought
Maintained
Sold
Other funds holding ASMB
T. Rowe Price Associates's ASMB Position: Q3 2026 in Review
T. Rowe Price Associates increased its Assembly Biosciences (ASMB) stake by 34% in Q3 2026, buying an estimated $80.6K and bringing the position to 11,022 shares worth $259K. The position accounts for ﹤0.01% of the portfolio, ranked #2911.
T. Rowe Price Associates first reported a position in ASMB in Q1 2018 and has held it in 9 quarters since. The position peaked at $18.2M in Q4 2019. 104 funds tracked by Wall St. Rank hold ASMB as of Q3 2026.
- T. Rowe Price Associates held 11,022 shares of Assembly Biosciences worth $259K as of Q3 2026.
- T. Rowe Price Associates bought 2,819 Assembly Biosciences shares in Q3 2026, an estimated $80.6K.
- Assembly Biosciences made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q3 2026, its #2911 holding.
- T. Rowe Price Associates first reported a position in Assembly Biosciences in Q1 2018 and has held it in 9 quarters since.
- T. Rowe Price Associates's Assembly Biosciences position peaked at $18.2M in Q4 2019.
- 104 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2026.
Based on T. Rowe Price Associates's 13F filing for Q3 2026, filed 16 Nov 2026.